Copyright
©The Author(s) 2023.
World J Gastroenterol. Feb 14, 2023; 29(6): 1090-1108
Published online Feb 14, 2023. doi: 10.3748/wjg.v29.i6.1090
Published online Feb 14, 2023. doi: 10.3748/wjg.v29.i6.1090
Table 2 Overall survival rates by background characteristics from 2000 to 2018
| Characteristics | China | United States | ||||
| 1-yr, % (95%CI) | 3-yr, % (95%CI) | 5-yr, % (95%CI) | 1-yr, % (95%CI) | 3-yr, % (95%CI) | 5-yr, % (95%CI) | |
| Total | ||||||
| Period of diagnosis | ||||||
| 1 (2000-2003) | 75.0 (63.2-89.0) | 54.5 (41.7-71.4) | 47.7 (35.0-65.0) | 58.4 (55.3-61.7) | 40.7 (37.7-44.0) | 36.2 (33.2-39.4) |
| 2 (2004-2008) | 80.1 (74.5-86.1) | 59.7 (52.9-67.3) | 54.1 (47.4-61.9) | 58.1 (55.4-61.0) | 42.3 (39.6-45.2) | 38.4 (35.7-41.3) |
| 3 (2009-2013) | 76.7 (72.3-81.3) | 57.1 (52.1-62.6) | 51.6 (46.6-57.2) | 60.8 (58.1-63.6) | 44.0 (41.2-46.9) | 39.7 (37.0-42.6) |
| 4 (2014-2018) | 88.6 (85.1-92.3) | 66.5 (60.8-72.7) | 61.6(58.9-64.4) | 43.0 (39.9-46.4) | ||
| Race | ||||||
| Chinese | 81.4 (78.9-84.1) | 60.9 (57.6-64.3) | 52.3 (48.8-56.0) | 66.0 (58.1-75.1) | 52.9 (44.4-62.9) | 42.9 (34.4-53.5) |
| White | 59.7 (58.1-61.5) | 41.7 (40.0-43.6) | 37.8 (36.0-39.6) | |||
| Black | 58.0 (54.3-61.8) | 42.7 (39.0-46.7) | 38.2 (34.6-42.3) | |||
| Others | 59.4 (55.6-63.5) | 43.3 (39.4-47.6) | 37.2 (33.3-41.6) | |||
| Gender | ||||||
| Male | 82.2 (78.7-85.8) | 61.5 (57.1-66.2) | 53.6 (49.0-58.7) | 57.0 (55.0-59.0) | 39.6 (37.6-41.7) | 34.8 (32.8-36.9) |
| Female | 80.6 (76.9-84.5) | 60.2 (55.5-65.3) | 50.7 (45.7-56.2) | 63.0 (61.0-65.1) | 46.2 (44.1-48.4) | 42.2 (40.1-44.4) |
| Primary tumor location | ||||||
| Proximal | 76.7 (69.8-84.2) | 47.7 (39.8-57.2) | 42.7 (34.7-52.4) | 59.0 (56.0-62.2) | 35.8 (32.8-39.1) | 30.5 (27.5-33.7) |
| Distal | 84.5 (81.8-87.3) | 66.3 (62.8-70.1) | 57.4 (53.5-61.5) | 64.6 (62.5-66.7) | 48.0 (45.8-50.4) | 42.9 (40.6-45.3) |
| Differentiation | ||||||
| Well | 100.0 (100.0-100.0) | 100.0 (100.0-100.0) | 85.7 (63.3-100.0) | 92.5 (88.9-96.2) | 83.3 (78.0-89.0) | 78.8 (72.6-85.6) |
| Moderate | 90.4 (84.7-96.6) | 76.1 (67.6-85.6) | 66.3 (56.4-78.0) | 72.3 (67.9-76.9) | 50.1 (45.2-55.5) | 44.6 (39.6-50.1) |
| Poor/Undifferentiated | 87.7 (84.8-90.7) | 69.6 (65.4-74.0) | 61.6 (57.0-66.5) | 48.3 (46.3-50.5) | 25.7 (23.9-27.6) | 19.9 (18.2-21.8) |
| Linitis plastica | ||||||
| Yes | 57.1 (39.5-82.8) | 14.3 (5.0-40.7) | 4.8 (0.7-32.2) | 49.5 (37.8-65.0) | 14.8 (7.6-29.0) | 12.3 (5.8-26.4) |
| No | 83.9 (81.4-86.6) | 68.7 (65.4-72.2) | 63.8 (60.2-67.5) | 60.0 (58.6-61.4) | 43.1 (41.6-44.6) | 38.6 (37.1-40.1) |
| Signet ring cell carcinoma | ||||||
| Yes | 91.0 (87.9-94.2) | 80.3 (75.8-85.0) | 76.9 (72.1-82.1) | 49.5 (37.8-65.0) | 14.8 (7.6-29.0) | 12.3 (5.8-26.4) |
| No | 90.2 (86.7-93.8) | 75.1 (70.0-80.6) | 70.8 (65.2-76.8) | 60.0 (58.6-61.4) | 43.1 (41.6-44.6) | 38.6 (37.1-40.1) |
| pTNM stage (AJCC TNM 8th) | ||||||
| I | 100.0 (100.0-100.0) | 99.4 (98.4-100.0) | 99.4 (98.4-100.0) | 91.5 (89.3-93.8) | 86.4 (83.6-89.2) | 83.4 (80.2-86.6) |
| II | 97.1 (94.3-99.9) | 83.6 (77.5-90.3) | 69.8 (61.9-78.7) | 84.2 (80.4-88.2) | 68.4 (63.4-73.8) | 61.0 (55.5-67.0) |
| III | 83.5 (79.4-87.9) | 54.9 (49.3-61.0) | 42.6 (37.0-49.2) | 74.8 (70.9-78.8) | 41.0 (36.5-46.1) | 29.6 (25.3-34.7) |
| IV | 51.2 (43.8-59.7) | 17.4 (12.3-24.8) | 9.9 (6.0-16.3) | 29.7 (27.5-32.1) | 10.4 (8.8-12.1) | 7.1 (5.7-8.7) |
| Surgery | ||||||
| Yes | 89.6 (87.3-92.0) | 72.4 (69.0-76.0) | 63.4 (59.5-67.5) | 82.6 (80.9-84.3) | 61.2 (59.0-63.5) | 53.6 (51.3-56.1) |
| No | 58.4 (51.8-65.9) | 33.4 (26.9-41.5) | 28.7 (22.2-37.0) | 43.2 (41.3-45.1) | 29.1 (27.4-31.0) | 27.0 (25.3-28.9) |
| Chemotherapy | ||||||
| Yes | 89.1 (85.8-92.6) | 67.0 (61.9-72.6) | 52.7 (47.1-59.1) | 55.9 (54.1-57.8) | 32.7 (31.0-34.6) | 27.4 (25.7-29.2) |
| No | 76.8 (73.3-80.4) | 57.2 (53.1-61.6) | 51.9 (47.7-56.5) | 66.4 (64.2-68.6) | 59.2 (56.9-61.6) | 56.2 (53.9-58.7) |
| Lymphadenectomy | ||||||
| Yes | 90.8 (88.4-93.2) | 77.7 (74.3-81.3) | 73.7 (69.9-77.6) | 70.9 (67.9-73.9) | 39.4 (36.2-42.8) | 29.2 (26.1-32.6) |
| No | 64.0 (58.3-70.3) | 41.4 (35.4-48.5) | 35.1 (29.0-42.5) | 57.2 (55.6-58.8) | 43.7 (42.1-45.4) | 40.7 (39.1-42.4) |
| Lymphadenectomy with at least 15 lymph nodes | ||||||
| Yes | 91.8 (89.3-94.3) | 79.9 (76.2-83.3) | 76.2 (72.2-80.6) | 77.3 (73.7-81.1) | 43.4 (39.4-48.6) | 32.4 (28.1-37.2) |
| No | 86.5 (80.4-93.1) | 69.0 (60.9-78.3) | 64.1 (55.6-73.8) | 63.0 (58.4-67.9) | 34.0 (29.6-39.1) | 25.3 (21.2-30.2) |
- Citation: Niu PH, Zhao LL, Wang WQ, Zhang XJ, Li ZF, Luan XY, Chen YT. Survival benefit of younger gastric cancer patients in China and the United States: A comparative study. World J Gastroenterol 2023; 29(6): 1090-1108
- URL: https://www.wjgnet.com/1007-9327/full/v29/i6/1090.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i6.1090